Opinion
In this consolidated proceeding we consider the authority of the Board of Medical Quality Assurance (Bus. & Prof. Code, § 2001) to subpoena the medical records of a physician’s patients without their consent. The board, in the course of investigations of Drs. Wood and Linn (petitioners), issued administrative subpoenas (Gov. Code, § 11181) requiring them to produce the complete medical records of named patients. Each refused to comply and the board sought judicial enforcement of the subpoenas. (Gov. Code, § 11187.) The trial court upheld the board and ordered cоmpliance with the subpoenas. Each doctor petitioned this court for a writ of mandate overturning the orders. Although the orders requiring compliance with the subpoenas are appealable as final judgments in special proceedings
(Franchise Tax Board
v.
Barnhart
(1980)
Facts
The board is charged with the duty of investigating claims of unprofessional conduct. (Bus. & Prof. Code, § 2220.) It conducts routine audits of pharmacy records of prescriptions for schedule II controlled substances. 1 (Bus. & Prof. Code, § 4331.) The audits of prescriptions written by petitioners made board investigators suspicious of the propriety of their issuance. Health and Safety Code section 11210 provides that a physician may only prescribe controlled substances with a good faith belief that it is a required treatment for a patient’s ailment and only in a quantity and for a time that is reasonably necessary. A violation of this provision is unprofessional conduct (Bus. & Prof. Code, § 2238, former § 2391.5 [Stats. 1947, eh. 309, p. 867, § 1]) and subjects the violator to disciplinary action by the board (Bus. & Prof. Code, § 2234, former § 2361 [Stats. 1937, ch. 414, p. 1377]). The board issued administrative subpoenas for “the complete medical records pertaining to” 16 of Wood’s patients and 36 of Linn’s patients who had been prescribed schedule II drugs in circumstances deemed suspicious by board personnel. The ground of these suspicions is set forth in the affidavits tendered in support of the respective subpoenas.
The Wood Subpoena
The declaration of Lynn Sullivan, an investigator for the board, alleges she was “conducting a routine pharmacy audit at Galt Pharmacy” in June 1981, when a pharmacist referred her to “numerous prescriptions for large quantities of Demerol written by” Dr. Wood for a patient. The pharmacist told Sullivan “he believed [the patient] is receiving excessive doses of Demerol.” Sullivan then obtained copies from the Department of Justice of all Schedule II controlled substance prescriptions written by Wood from April 1980, through March 1981. In her opinion a review of these prescriptions showed Wood was prescribing larger quantities of these drugs and for *1142 longer periods than usual for a general practitioner in the community. Sullivan went to various additional pharmacies to collect information on Wood’s prescription practices. She compiled information on 16 patients for whom Wood had prescribed schedule II controlled substances. Her declaration lists each patient, the drugs prescribed, and the duration of the prescription. In most instances she relates a brief notation of the purpose for the prescription ostensibly written thereon by Wood, e.g., “insomnia,” “chronic shoulder disease,” “рain,” “sleep,” “nerves and hypertensive behavior.” Additionally, she avers that a pharmacist at the All-Med Pharmacy told her one of the listed patients was diagnosed by Wood as having narcolepsy and had been receiving Ritalin for three to four years. The pharmacist “questioned” the diagnosis and said he believed the patient is addicted to the drug and “may” be abusing it.
The other declaration in support of the Wood subpoena is that of Dr. Schwamb, a board medical consultant. He reviewed the evidence compiled by Sullivan and concludes “because of the definite possibility of excessive prescribing of controlled drug substances ... in my professional opinion there is a need to obtain the medical records of these patients . . . for further review as to the medical indications for the prescribing of the controlled drug substances and to clarify the medical reasons for the apparent excessive amounts of controlled drug substances being prescribed and to see if appropriate medical conditions or pathology exists to warrant such prescribing and whether good faith physical examinations are being performed initially and in the course of continued prescribing.”
Wood opposed enforcement of the subpoena by filing, inter alia, declarations of six local physicians, all of whom asserted that the facts listed in the Sullivan and Schwamb declarations did not “per se” indicate improper prescribing practices in the community. They each could conceive of a variety of circumstances in which the types and amounts of medications prescribed would be appropriate. Each claimed he was an experienced practitioner (from 12 to 26 years experience) and was familiar with the medications in question.
Wood also submitted the declarations of two pharmacists from the All-Med Pharmacy. Both emphatically denied telling Sullivan the patient was addicted to Ritalin or questioning the diagnosis. One pharmacist declared the patient was a regular customer of All-Med and neither “his demeanor or the amount of Ritalin consumed appeared abnormal at any time.”
The Linn Subpoena
The declaration of Harold Keener, a board investigator, states: “an investigation was assigned to me that was initiated by the Sacramento County *1143 Sheriff’s Office and the Bureau of Narcotic Enforcement. Allegations are Dr. Linn is prescribing large amounts of schedule II controlled substances to various persons over extended periods of time.” Keener interviewed various pharmacists and obtained copies of Linn’s Schedule II controlled substances prescriptions. He compiled profiles for 36 patients listing drugs prescribed and durations. Again, some patients’ prescriptions contained brief notations of reasons for the prescriptions, e.g., “аppetite,” “severe pain.” Keener interviewed Linn concerning the 36 patients. He obtained “information” (no further specification provided) during the interview concerning six of the patients indicating Linn “may” be guilty of repeated acts of clearly excessive prescribing of drugs as determined by the standard of the local community of doctors. Keener supplied his compiled information on the patients’ prescriptions to Dr. Schwamb.
Schwamb’s declaration relates the information he received from Keener and avers for each patient sоme variation of the formula opinion: “The medical record should be procurred [sz'c] to ascertain any medical condition warranting such a long duration of prescribing such large amounts of the controlled drug.” Five of the formula opinions contain the allegation that the different drugs prescribed for the patient have contradictory effects.
Linn refused to comply with the subpoena. He opposed judicial enforcement, claiming the amounts and types of prescriptions were not in excess of those dictated by the patients’ needs. Linn submitted the declaration of Dr. McKibbin, a surgeon to whom some of the patients had been referred for consultation. McKibbin had retired two years before. He declared he had practiced medicine for 34 years and that, of the hundreds of patients (unidentified) referred to him by Linn, none had been prescribed excessive amounts of medication.
Discussion
I.
Petitioners challenge the enforcement of the subpoenas on several grounds. They first argue that the board is denied authority to subpoena the records of patients from a physician’s office by Business and Professions Code section 2225. 2 They rely on this provision: “The board’s *1144 authority to examine records of patients in the office of a physician ... is limited to records of patients who have complained to the board about [the physician].” (Italics added.) This proviso is susceptible to two readings: “in the office” either specifies the source of the records to be examined or the place of their examination. The petitioners read it the first way, as a blanket denial of access, absent a patient complaint, to records which are located in the office of the physician. The board reads it the second way, as a prohibition against rummaging through patiеnt records in the office of the physician. This latter reading permits access by subpoena to patient records without patient complaint. We adopt this as the correct reading.
The proviso at issue in section 2225 is conditioned by this sentence: “Notwithstanding Section 2263 and any other provision of law making a communication between a physician . . . and his or her patients a privileged communication, such provisions shall not apply to investigations or proceedings conducted under this chapter.” (Ibid.; italics added.) It stems from a reorganization of the Medical Practice Act (Stats. 1980, ch. 1313, p. 4443 foil.) and is a lineal descendant of a 1965 amendment to former section 2379. (Compare Stats. 1937, ch. 414, p. 1377 with Stats. 1965, ch. 1458, § 7, p. 3415.) Section 2379 then said: “Neither this section nor any other provision of law making communication between a physician and surgeon and his patient a privileged communication shall apply to investigations or proceedings conducted under this act.” (Stats. 1965, ch. 1458, § 7, p. 3415; italics added.) With this proviso the in-office records were made a privileged communication but subject to “investigations or proceedings conducted under this act.” Thus while the board was prevented from rummaging through the records of noncomplaining patients in the office of the physician it was not рrohibited from securing them by the appropriate use of an administrative subpoena. The current provisions of section 2225 should be read as continuing these rules. No provision of law relating to the doctor-patient privilege, including section 2225 itself, applies to board investigations or proceedings.
Thus the statutory limitation is addressed solely to the securing of patient records “in the office of a physician” absent patient complaint. We are confirmed in this view by our conclusion that the privacy rights of patients can reasonably be accommodated in the calculus of cause sufficient for the issuance of an administrative subpoena. We will discuss that issue after a short detour.
*1145 II.
The board, somewhat tentatively, calls into question the right of the doctors to assert the privacy interest of their patients who have not consented to disclosure. It suggests that the doctors ought not be allowed to raise the privacy interests of their patients when suspected of conduct detrimental to them. It cites to
Pating
v.
Board of Medical Quality Assurance
(1982)
in.
The petitioners contend it was error to grant the judicial imprimatur to the administrative subpoenas because “good cause” for their issuance was not shown. They derive the requirement of good cause from
Board of Medical Quality Assurance
v.
Gherardini
(1979)
The board places its primary reliance upon
Brovelli
v.
Superior Court
(1961)
Brovelli
arose from “an investigation commenced by the attorney general to determine whether the Cartwright Act or the Unfair Practices Act was being violated by the concrete block industry . . . .”
(Id.,
at p. 526; see also
Younger
v.
Jensen
(1980)
*1147
In any event, the Fourth Amendment and the cognate provisions of the California Constitution, article I, section 13 are now supplemented by the right of privacy guaranteed by article I of the California Constitution. (See
Board of Medical Quality Assurance
v.
Gherardini, supra,
However, the privacy amendment “does not purport to prohibit all incursion into individual privacy but rather [requires] that any such intervention must be justified by a
compelling interest.
”
(White
v.
Davis, supra,
However, that only determines the nature of the compelling interest. It does not complete the constitutional equation. An impairment of an interest of constitutional dimension passes constitutional muster only if it is
necessary
to achieve the compelling interest. (See
City of Carmel-By-The Sea
v.
Young
(1970)
That brings us to a more precise formulation of the issues. The board has an interest only in the records which are “relevant and material” to the subject under inquiry, the medical propriety of the issuance of the Schedule II prescriptions. (See
Doyle
v.
State Bar of California
(1982)
The first constraint appropriate to accommodate the privacy interest of the patient is that the board must take reasonable steps to notify the patient of its proposed examination. (See
Valley Bank of Nevada
v.
Superior Court
(1975)
Second, if the patient does not waive the privacy interest, the board’s showing must provide competent evidence that permits the trial court to make an independent finding of good cause. The board must demonstrate that the particular records it seeks are “relevant and material to the board’s inquiry” whether the petitioners have improperly prescribed Schedule II drugs. (See
Doyle
v.
State, supra,
The first mentioned defect is the more obvious. No facts are presented in the affidavits that explain why the demands for the “complete” records of the patients are not excessive, i.e., why they do not exceed the scope of concern generated by the audits of petitioners’ Schedule II prescriptions. In the context of patient records we see no reason why the board should not be charged with limiting its requests for records to those essential to a focused inquiry. (Compare Gov. Code, § 7470, no disclosure of financial records “unless the financial records are described with particularity and are consistent with the scope and requirements of the investigation giving rise to such request ....”)
Where the physician is cooperative, a dialogue concerning the board’s misgivings and the justification tendered for the prescription seems a sensible measure to limit the degree of intrusion on patient privacy and to set the stage, if necessary, for a particularized demand for records, i.e., one that relates the specific ground of concern to a medical condition of the *1150 patient which is related to that concern. Where the physician does not cooperate, the board has means by which to compel the doctor to justify on medical grounds the prescriptions which are the subject of the inquiry. (See Gov. Code, § 11181, subd. (e).) If the physician tenders a particular justification for suspicious conduct, the scope of the investigation is narrowed to evidence corroborating, penetrating or refuting the claim. In any event, the board must identify the particular records that contain pertinent information and, unless it is obvious to a layperson, show why that information must be obtained to resolve the investigation.
Overbreadth is not the only deficiency of the subpoenas tendered here to the trial court. They also suffer from a lack of sufficient factual justification to permit the trial court to independently assess the substantiality of the likelihood of improper prescription practices. If the trial court is to make the dеcision of reasonable cause other than as a rubber stamp the root facts upon which an inference of improper prescribing is based must be laid bare. Here we have some facts about the prescriptions and the conclusions of board personnel that they are suspicious but no mediating facts revealing why the conclusion is warranted. The board has made no evidentiary showing of how often physicians similarly-situated to petitioners might prescribe these drugs. Alternatively, the board has made no showing of the likelihood that the prescriptions сould have been properly issued, given what is known of the circumstances of issuance. Absent this information the trial court has no means by which to gauge the likelihood that the records sought will reveal physician misconduct. Without this there can be no independent judicial assessment of good cause. The judicial function of assessing cause (see 8 Wigmore, Evidence (McNaughton rev. ed. 1961) § 2195) cannot be abdicated by deferring to the bare conclusions of board personnel.
Let a peremptory writ issue directing the respondent court to set aside the judgments (orders for compliance with subpoenas). The alternative writs are discharged.
Sparks, J., and Miller, J., * concurred.
The petitions of real party in interest for review by the Supreme Court were denied June 20, 1985.
Notes
The prescription of certain drugs with potential for dangerous abuse is regulated by state and federal statutes. (See 21 U.S.C. § 801 et seq; Health & Saf. Code, § 11150 et seq.) Some of these drugs are designated as schedule H controlled substances. (Health & Saf. Code, § 11055.) Schedule II drugs must be prescribed on triplicate forms issued by the Department of Justice in serially numbered groups. (Health & Saf. Code, §§ 11161, 11164.) The pharmacist retains the original оf the prescription and must transmit one copy to the Department of Justice. (Health & Saf. Code, § 11164.) Presumably the board is entitled to receive these pursuant to Civil Code section 1798.24, subdivision (e). The prescriber must make an additional record of the name and address of the patient, the date, the character and quantity of the drug and the pathology and purpose for which the drug is prescribed. (Health & Saf. Code, § 11190.)
All nondescript statutory references are to the Business and Professions Code. Section 2225 provides in relevant part: “Notwithstanding Section 2263 and any other provisiоn of law making a communication between a physician and surgeon or a podiatrist and his or her patients a privileged communication, such provisions shall not apply to investigations or proceedings conducted under this chapter. Members of the board and the Podiatry Examining Committee, and employees, agents, and representatives of the board shall keep in *1144 confidence during the course of investigations, the names of any patients whose records are reviewed and may not disclose or reveal, except as is necessary during thе course of an investigation, such names unless and until proceedings are instituted. The board’s authority to examine records of patients in the office of a physician and surgeon or a podiatrist is limited to records of patients who have complained to the board about such licensee.”
This is implicit in both lines of reasoning displayed in
People
v.
Hyde
(1974)
We are confirmed in this view by the previously discussed prohibition on board examination of patient records on demand that is contained in Business and Professions Code section 2225. Civil Code section 56.10 embodies a similar notion broadly applicable to all licensed health practitioners. Section 56.10, subdivision (c), permits certain disclosures by practitioners without civil liability to the patient for breаch of confidence. Section 56.10, subdivision (c)(5), provides: “The information in the possession of any provider of health care may be reviewed by any private or public body responsible for licensing or accrediting the provider of health care. However, no patient identifying medical information may be removed from the premises except as expressly permitted or required elsewhere by law.” We note also the legislative finding that the privacy interest of the patient in these records suffices to compel the application of a probable cause standard in a criminal investigation. (See Pen. Code, §§ 1524, 1525; compare with Pen. Code, § 1543 foil.)
Assigned by the Chairperson of the Judicial Council.
